Results 151 to 160 of about 125,969 (167)
Some of the next articles are maybe not open access.
Drug Discovery Today, 2020
Endocannabinoid degrading enzymes regulate the concentrations of a variety of biomolecules, many of which are consequential in clinical pathologies. Monoacylglycerol lipase (MAGL) is the major enzyme involved in endocannabinoid (2-AG) hydrolysis.
N. Grimsey +3 more
semanticscholar +1 more source
Endocannabinoid degrading enzymes regulate the concentrations of a variety of biomolecules, many of which are consequential in clinical pathologies. Monoacylglycerol lipase (MAGL) is the major enzyme involved in endocannabinoid (2-AG) hydrolysis.
N. Grimsey +3 more
semanticscholar +1 more source
Assay of Monoacylglycerol Lipase Activity.
Methods in molecular biology, 2023Kwang-Mook Jung, D. Piomelli
semanticscholar +1 more source
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Expert Opinion on Therapeutic Patents, 2021Giulia Bononi +2 more
exaly
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
Cell, 2010Daniel K Nomura +2 more
exaly
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Angewandte Chemie - International Edition, 2014Gloria Hernández-Torres +2 more
exaly
Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
ChemBioChem, 2010Geoffray Labar, Johan Wouters
exaly
Monoacylglycerol lipase – a target for drug development?
British Journal of Pharmacology, 2012Christopher Fowler
exaly